Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report) shares dropped 5% during mid-day trading on Thursday . The stock traded as low as $14.33 and last traded at $14.53. Approximately 696,839 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 13,242,744 shares. The stock had previously closed at $15.29.
Regencell Bioscience Trading Down 0.7%
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Regencell Bioscience stock. Greenfield Savings Bank bought a new stake in Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 11,000 shares of the company's stock, valued at approximately $187,000. 0.13% of the stock is currently owned by institutional investors and hedge funds.
About Regencell Bioscience
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
See Also
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
